Total Payments
$1.0M
2024 Payments
$171,259
Companies
65
Transactions
1,778
Medicare Patients
4,328
Medicare Billing
$486,199
Payment Breakdown by Category
Other$828,247 (82.2%)
Travel$112,490 (11.2%)
Consulting$34,017 (3.4%)
Food & Beverage$32,238 (3.2%)
Education$26.32 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $828,247 | 405 | 82.2% |
| Travel and Lodging | $112,490 | 450 | 11.2% |
| Consulting Fee | $34,017 | 20 | 3.4% |
| Food and Beverage | $32,238 | 899 | 3.2% |
| Education | $26.32 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $926,994 | 1,169 | $0 (2024) |
| Mylan Specialty L.P. | $71,072 | 151 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,478 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $815.30 | 65 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $570.71 | 38 | $0 (2023) |
| Grifols USA, LLC | $551.80 | 16 | $0 (2022) |
| Gilead Sciences, Inc. | $441.57 | 19 | $0 (2021) |
| ABBVIE INC. | $344.58 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $305.38 | 16 | $0 (2024) |
| Philips Electronics North America Corporation | $275.96 | 19 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $171,259 | 227 | AstraZeneca Pharmaceuticals LP ($167,904) |
| 2023 | $170,119 | 252 | AstraZeneca Pharmaceuticals LP ($163,562) |
| 2022 | $183,638 | 262 | AstraZeneca Pharmaceuticals LP ($172,608) |
| 2021 | $168,741 | 289 | AstraZeneca Pharmaceuticals LP ($163,434) |
| 2020 | $23,902 | 88 | AstraZeneca Pharmaceuticals LP ($14,178) |
| 2019 | $62,864 | 189 | Mylan Specialty L.P. ($40,168) |
| 2018 | $94,630 | 216 | AstraZeneca Pharmaceuticals LP ($93,646) |
| 2017 | $131,865 | 255 | AstraZeneca Pharmaceuticals LP ($130,098) |
All Payment Transactions
1,778 individual payment records from CMS Open Payments — Page 1 of 72
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $581.95 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $503.95 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $145.21 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $103.12 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $50.56 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $136.68 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $99.96 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.56 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $40.20 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $275.82 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $169.36 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $150.86 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $122.79 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Respiratory | ||||||
| 10/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.56 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $40.20 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 976 | 1,304 | $207,234 | $108,932 |
| 2022 | 7 | 883 | 1,238 | $203,989 | $103,984 |
| 2021 | 11 | 1,140 | 1,532 | $235,130 | $128,916 |
| 2020 | 13 | 1,329 | 1,803 | $216,724 | $144,367 |
Total Patients
4,328
Total Services
5,877
Medicare Billing
$486,199
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 19 | 19 | $494.00 | $313.88 | 63.5% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2021 | 199 | 203 | $1,015 | $7.10 | 0.7% |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | Office | 2021 | 24 | 24 | $120.00 | $3.99 | 3.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 344 | 733 | $117,280 | $81,070 | 69.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 175 | 175 | $40,250 | $26,909 | 66.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 123 | 145 | $17,400 | $11,403 | 65.5% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 242 | 246 | $20,910 | $11,275 | 53.9% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 53 | 61 | $9,455 | $6,373 | 67.4% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 16 | 16 | $4,280 | $3,618 | 84.5% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2020 | 40 | 85 | $2,125 | $1,297 | 61.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 36 | 36 | $1,800 | $1,009 | 56.0% |
| 90653 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 11 | $825.00 | $651.26 | 78.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 26 | 26 | $676.00 | $429.43 | 63.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 18 | $468.00 | $297.45 | 63.6% |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 2020 | 186 | 191 | $955.00 | $18.62 | 1.9% |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | Office | 2020 | 60 | 60 | $300.00 | $16.20 | 5.4% |
About Dr. George Parides, DO
Dr. George Parides, DO is a Pulmonary Disease healthcare provider based in Mesa, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851379879.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Parides, DO has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $171,259 received in 2024. These payments were reported across 1,778 transactions from 65 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($828,247).
As a Medicare-enrolled provider, Parides has provided services to 4,328 Medicare beneficiaries, totaling 5,877 services with total Medicare billing of $486,199. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Mesa, AZ
- Active Since 01/09/2006
- Last Updated 04/01/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1851379879
Products in Payments
- BREZTRI (Drug) $537,712
- BEVESPI AEROSPHERE (Drug) $189,906
- AIRSUPRA (Drug) $92,978
- Yupelri (Drug) $64,065
- SYMBICORT (Drug) $43,208
- FASENRA (Biological) $26,586
- BREZTRI AEROSPHERE (Drug) $14,175
- DALIRESP (Drug) $7,419
- YUPELRI (Drug) $7,007
- XIFAXAN (Drug) $449.58
- TRELEGY ELLIPTA (Drug) $422.07
- FASENRA (Drug) $370.35
- Prolastin-C Liquid (Biological) $345.70
- FARXIGA (Drug) $325.86
- DUPIXENT (Biological) $322.27
- STIOLTO RESPIMAT (Drug) $239.96
- STELARA (Biological) $221.99
- Prolastin-C (Biological) $206.10
- IBSRELA (Drug) $198.21
- TYVASO (Drug) $191.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Mesa
Dr. Steven Farber, Do, DO
Pulmonary Disease — Payments: $21,369
Pulmonary Disease $21,369
Dr. Robert Groves, M.d, M.D
Pulmonary Disease — Payments: $4,541
Pulmonary Disease $4,541
G Sulit, Md, MD
Pulmonary Disease — Payments: $4,060
Pulmonary Disease $4,060
Alhassan Badahman, M.d, M.D
Pulmonary Disease — Payments: $3,937
Pulmonary Disease $3,937
Dashant Kavathia, Md, MD
Pulmonary Disease — Payments: $3,271
Pulmonary Disease $3,271
Seyed Javadpoor, Md, MD
Pulmonary Disease — Payments: $3,044
Pulmonary Disease $3,044